REPLIGEN CORP

RGEN - Company ID 0000730272

Market cap$8.12 B

Rank#1079

Filings1,331

REPLIGEN CORP has filed 1,331 public company documents between 1995 and 2026. The most frequent type is insider trade (594 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchRGEN overview$8.12 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #1079See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with AMGNPeer viewPut RGEN beside AMGN across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow RGEN via RSS

Similar companies to research next

AMGNAmgen Inc.

GILDGilead Sciences, Inc.AARGXargenx SE RRVMDRevolution Medicines, Inc.

MRNAModerna, Inc.

BIIBBiogen Inc.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
PRE 14A	PRE 14A	1y ago2025-03-17	2025-03-17	View filing
PRE 14A	PRE 14A	3y ago2023-03-24	-	View filing
PRE 14A	PRE 14A	9y ago2017-04-07	2017-05-18	View filing
PRE 14A	PRE 14A	12y ago2014-03-21	2014-05-15	View filing
PRE 14A	PRE 14A	23y ago2003-07-10	2003-09-10	View filing
PRE 14A	PRE 14A	24y ago2002-07-05	2002-09-12	View filing
PRE 14A	PRE 14A	26y ago1999-07-19	1999-09-16	View filing

REPLIGEN CORP

Similar companies to research next

Year